EUVIMEDEUVIMED entdecken
Leserbrief

Effect of cytochrome P450 1A2 inhibitors on rhabdomyolysis in patients on clozapine: Analysis using the US Food and Drug Administration's Adverse Event Reporting System

Kazumasa Kotake, Satoru Mitsuboshi, Tomonari Hosokawa, Naoya Kitamura, Yasuhiro Kawakami

Schizophrenia Research · 2023

DOI: 10.1016/j.schres.2023.10.042 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Schizophrenia Research, 2023. Verfasst von Kazumasa Kotake und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Okayama Saiseikai General Hospital, Okayama, Japan. Electronic address: kottanketty@gmail.com. Hauptthemen laut MEDLINE: Clozapine, Rhabdomyolysis, Cytochrome P-450 CYP1A2 Inhibitors, Antipsychotic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClozapineRhabdomyolysisCytochrome P-450 CYP1A2 InhibitorsAntipsychotic AgentsHumansUnited StatesUnited States Food and Drug Administration

Substanzen

ClozapineCytochrome P-450 CYP1A2 InhibitorsAntipsychotic Agents

Autor:innen und Institutionen

  • Department of Pharmacy, Okayama Saiseikai General Hospital, Okayama, Japan. Electronic address: kottanketty@gmail.com.
  • Department of Pharmacy, Kaetsu Hospital, Niigata, Japan.
  • Department of Psychiatry, Zikei Hospital/Zikei Institute of Psychiatry, Okayama, Japan.
  • Department of Neuropsychiatry, Okayama Saiseikai General Hospital, Okayama, Japan.
  • Department of Pharmacy, Okayama Saiseikai General Hospital, Okayama, Japan.

Zitieren

APA

Kotake, K., Mitsuboshi, S., Hosokawa, T., Kitamura, N., & Kawakami, Y. (2023). Effect of cytochrome P450 1A2 inhibitors on rhabdomyolysis in patients on clozapine: Analysis using the US Food and Drug Administration's Adverse Event Reporting System. Schizophrenia Research. https://doi.org/10.1016/j.schres.2023.10.042

Vancouver

Kotake K, Mitsuboshi S, Hosokawa T, Kitamura N, Kawakami Y. Effect of cytochrome P450 1A2 inhibitors on rhabdomyolysis in patients on clozapine: Analysis using the US Food and Drug Administration's Adverse Event Reporting System. Schizophrenia Research. 2023. doi:10.1016/j.schres.2023.10.042

BibTeX
@article{Kotake2023,
  author = {Kotake, Kazumasa and Mitsuboshi, Satoru and Hosokawa, Tomonari and Kitamura, Naoya and Kawakami, Yasuhiro},
  title = {Effect of cytochrome P450 1A2 inhibitors on rhabdomyolysis in patients on clozapine: Analysis using the US Food and Drug Administration's Adverse Event Reporting System},
  journal = {Schizophrenia Research},
  year = {2023},
  doi = {10.1016/j.schres.2023.10.042}
}
Kostenlos starten →